Cardiovascular risk assessment in metabolic syndrome: view from PROCAM

被引:18
作者
Assmann, G
Nofer, JR
Schulte, H
机构
[1] Univ Munster, Inst Klin Chem, D-48129 Munster, Germany
[2] Univ Munster, Lab Med, D-48129 Munster, Germany
[3] Univ Munster, Inst Arterioskleroseforsch, D-4400 Munster, Germany
关键词
D O I
10.1016/j.ecl.2004.03.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The near-epidemic proportions of diabetes mellitus and the metabolic syndrome over the past years are widely ascribed to a changing socioeconomic environment that contributes to excessive nutritional intake and sedentary lifestyle. Paradoxically, this gives room for expectations, because timely lifestyle and dietary intervention could decelerate the progression of diabetes, reduce the rate of development of cardiovascular complications, and reduce costs associated with treatment and rehabilitation. This approach, however, depends on the development of tools that allow precise estimation of risk of cardiovascular complications before the onset of diabetes mellitus and the risk of developing type 2 diabetes itself. This article reviews the progress that has been made toward reaching these goals based on the results of the PROspective Cardiovascular Munster (PROCAM) study.
引用
收藏
页码:377 / +
页数:17
相关论文
共 32 条
[1]   Effects of free fatty acids (FFA) on glucose metabolism: Significance for insulin resistance and type 2 diabetes [J].
Boden, G .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2003, 111 (03) :121-124
[2]   Free fatty acids in obesity and type 2 diabetes:: defining their role in the development of insulin resistance and β-cell dysfunction [J].
Boden, G ;
Shulman, GI .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 :14-23
[3]  
Borch-Johnsen K, 1999, LANCET, V354, P617
[4]   Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin : cholesterol acyltransferase and lipid transfer proteins [J].
Borggreve, SE ;
de Vries, R ;
Dullaart, RPF .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (12) :1051-1069
[5]   RISK-FACTORS FOR NIDDM IN WHITE-POPULATION - PARIS PROSPECTIVE-STUDY [J].
CHARLES, MA ;
FONTBONNE, A ;
THIBULT, N ;
WARNET, JM ;
ROSSELIN, GE ;
ESCHWEGE, E .
DIABETES, 1991, 40 (07) :796-799
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   WEIGHT-GAIN AS A RISK FACTOR FOR CLINICAL DIABETES-MELLITUS IN WOMEN [J].
COLDITZ, GA ;
WILLETT, WC ;
ROTNITZKY, A ;
MANSON, JE .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (07) :481-486
[8]   INCIDENCE OF TYPE-II DIABETES IN MEXICAN-AMERICANS PREDICTED BY FASTING INSULIN AND GLUCOSE-LEVELS, OBESITY, AND BODY-FAT DISTRIBUTION [J].
HAFFNER, SM ;
STERN, MP ;
MITCHELL, BD ;
HAZUDA, HP ;
PATTERSON, JK .
DIABETES, 1990, 39 (03) :283-288
[9]   Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects -: Implications for preventing coronary heart disease during the prediabetic state [J].
Haffner, SM ;
Mykkänen, L ;
Festa, A ;
Burke, JP ;
Stern, MP .
CIRCULATION, 2000, 101 (09) :975-980
[10]   CARDIOVASCULAR RISK-FACTORS IN CONFIRMED PREDIABETIC INDIVIDUALS - DOES THE CLOCK FOR CORONARY HEART-DISEASE START TICKING BEFORE THE ONSET OF CLINICAL DIABETES [J].
HAFFNER, SM ;
STERN, MP ;
HAZUDA, HP ;
MITCHELL, BD ;
PATTERSON, JK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (21) :2893-2898